Gentest Corporation

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Contact Details: MA United States of America Tel: 617 935 5115 Fax: 617 938 8644 Email:

Recent Publications by Gentest Corporation:
Determination of CYP4A11-catalyzed lauric acid 12-hydroxylation by high-performance liquid chromatography with radiometric detection. The solution-phase synthesis of amido-, urea-, and aminofuranoses was...	12th December, 2003	GENTEST Corporation, Woburn, MA, USA.	Methods Mol Biol. 1998;107:163-7. DOI Direct Link
CYP2D6-dependent bufuralol 1'-hydroxylation assayed by reversed-phase ion-pair high-performance liquid chromatography with fluorescence detection. The solution-phase synthesis of amido-, urea-, and aminofuranoses was...	12th December, 2003	GENTEST Corporation, Woburn, MA, USA.	Methods Mol Biol. 1998;107:141-5. DOI Direct Link
CYP2C19-mediated (S)-mephenytoin 4'-hydroxylation assayed by high-performance liquid chromatography with radiometric detection. The solution-phase synthesis of amido-, urea-, and aminofuranoses was...	12th December, 2003	GENTEST Corporation, Woburn, MA, USA.	Methods Mol Biol. 1998;107:135-9. DOI Direct Link
Determination of CYP2C9-catalyzed diclofenac 4'-hydroxylation by high-performance liquid chromatography. The solution-phase synthesis of amido-, urea-, and aminofuranoses was...	12th December, 2003	GENTEST Corporation, Woburn, MA, USA.	Methods Mol Biol. 1998;107:129-33. DOI Direct Link
High-performance liquid chromatographic analysis of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation. The solution-phase synthesis of amido-, urea-, and aminofuranoses was...	12th December, 2003	GENTEST Corporation, Woburn, MA, USA.	Methods Mol Biol. 1998;107:123-7. DOI Direct Link
→View more Gentest Corporation research publications.

BioNews Results for Gentest Corporation:
Research on drug development discussed by K.A. Youdim and co-researchers	Calibre Macro World:  Jun 11 2008 10:36PM Matching: gentest

Gentest Corporation Patents:
US Patent No.	Title
6420131	Use of fluorescein aryl ethers in high throughput cytochrome P450 inhibition assays
6207404	Coumarin-based CYP3A fluorescent assay reagents
6130342	CYP2D fluorescent assay reagents
5726041	Method for detecting a receptor-ligand complex using a cytochrome P450 reporter gene
5429948	Human cell line stably expressing 5cDNAS encoding procarcinogen-activating enzymes and related mutagenicity assays
→View more Gentest Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 314 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: GENTEST Corporation | gentest corporation | gentest corporation | gentest uk | Gentest Corporation | gentest | Gentest corporation | Gentest corporation | gentest woburn usa | CYP3A | .

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Gentest Corporation

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.